000 01224 a2200325 4500
005 20250517123150.0
264 0 _c20171129
008 201711s 0 0 eng d
022 _a1365-2893
024 7 _a10.1111/jvh.12570
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aThompson, A J
245 0 0 _aVidal LL, et al. NS3 protease polymorphisms and genetic barrier to drug resistance of distinct HCV genotypes from worldwide treatment-naive subjects. JVH, 2016, 23(11): 840-849.
_h[electronic resource]
260 _bJournal of viral hepatitis
_c11 2016
300 _a838-839 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aAntiviral Agents
650 0 4 _aDrug Resistance
_xdrug effects
650 0 4 _aDrug Resistance, Viral
_xdrug effects
650 0 4 _aGenotype
650 0 4 _aHepacivirus
_xdrug effects
650 0 4 _aHepatitis C
650 0 4 _aHumans
650 0 4 _aPeptide Hydrolases
_xgenetics
650 0 4 _aProtease Inhibitors
650 0 4 _aViral Nonstructural Proteins
_xgenetics
700 1 _aBowden, D S
773 0 _tJournal of viral hepatitis
_gvol. 23
_gno. 11
_gp. 838-839
856 4 0 _uhttps://doi.org/10.1111/jvh.12570
_zAvailable from publisher's website
999 _c26569643
_d26569643